Expanded Capabilities AIT Bioscience joined Nexelis, expanding its portfolio with bioanalytical LC/MS and ligand binding platforms along with a modern electronic laboratory notebook. This creates a strong cross selling opportunity for sponsors seeking integrated testing across small and large molecule programs. Position as a single partner covering development stages across diverse therapeutic areas.

Quality and Compliance Nexelis has invested in GCLP certified clinical bioanalytical laboratories and has acquired related assets from GSK Germany. This regulatory quality footprint can be leveraged to win projects requiring audit readiness and GMP influenced standards. Opportunities to pitch to sponsors who demand GCLP plus global lab reach under one umbrella.

Growth and Backing The Nexelis growth narrative with ongoing acquisitions signals strong corporate support and scale. AIT clients can access broader capabilities and geographic reach through Nexelis, enabling larger projects and faster deployment. This backing reduces risk for sponsors pursuing multi site bioanalytical programs.

Agile Team Big Reach AIT is a small, agile operation that benefits from Nexelis infrastructure and corporate development resources. This means faster project kickoff and flexible staffing for mid to large scale studies while maintaining personalized service. A compelling sales angle is offering nimbleness with the reliability of a larger CRO.

US Presence Located in Indianapolis, AIT provides a strategic U.S. operation base within the Nexelis network. This regional footprint can streamline collaboration with North American sponsors and support rapid expansion of testing services for small and large molecules. Emphasize seamless ELN enabled workflows and integrated data management.